BIBL Inspire 100 ETF

Expense Ratio
0.35%
Dividend
1.11%
Previous close
$47.85
Est. 12 months change
+11.34%
Projected Price
$53.28

Profitability Metrics

Return on Equity (ROE)
31.91%
Return on Assets (ROA)
8.24%
Return on Invested Capital (ROIC)
26.87%
Weighted Average Cost of Capital (WACC)
9.61%
ROIC - WACC
17.26%
Updated : 2026-04-03 19:35 ET

Valuation Metrics

P/E Ratio
27.62
Forward P/E
25.03
PEG Ratio
3.47
Debt Current Ratio
1.66

Growth & Cash Flow

Gross Margin
48.19%
Operating Margin
23.94%
FCF Margin
27.92%
TTM Revenue Growth
14.37%
Projected 12M EPS Growth
10.35%

Price Change

Price % from 50 SMA
-1.50%
Price % from 200 SMA
6.00%
6 Months
6.50%
1 Year
22.94%
2 Years
24.58%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
CAT8.67%
KLAC4.94%
ANET3.78%
APH3.76%
WELL3.53%
PGR3.20%
PLD3.18%
PH2.85%
IBKR2.84%
VRT2.41%

ETF Analysis

Fund Overview

Inspire 100 ETF (BIBL) currently reports 100 stock positions (subject to change), placing it in the selectively diversified range by holdings breadth. The top line-up is CAT (8.67%), KLAC (4.94%), ANET (3.78%), with CAT as the largest single weight at 8.67%. Together, the top three holdings account for 17.39%, which points to a relatively flat weight distribution where no single cluster of names dominates outcomes. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.

Profitability & Capital Efficiency

Assessing the quality of returns on invested capital, ROIC is 26.87%, WACC is 9.61%, and the economic spread is 17.26%. On balance, the portfolio's businesses are clearing their capital cost hurdle with room to spare. Supporting metrics show ROE at 31.91% and ROA at 8.24%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

The market currently prices the portfolio at trailing P/E of 27.62, forward P/E of 25.03, PEG of 3.47. The gap between P/E and forward P/E is small, suggesting the valuation is not contingent on a near-term earnings step-change. The PEG ratio signals premium pricing — the portfolio's earnings growth expectations, while present, do not fully explain the current multiple on a purely quantitative basis. The current ratio of 1.66 is in an acceptable range, reflecting reasonable short-term financial health. Valuation and liquidity together frame a portfolio where the price paid today is a reasonable bet on earnings delivery — but not a margin-of-safety purchase at current levels.

Margins & Cash Generation

Looking at margins from gross to free cash flow, gross margin sits at 48.19%, operating margin at 23.94%, and free cash flow margin at 27.92%. Gross margins are constructive — not exceptional, but indicative of businesses with reasonable unit economics. At this level, operating margins reflect businesses that are scaling with discipline without dramatic cost pressure. Outstanding free cash flow margins signal businesses that convert revenues into cash at rates that support both reinvestment and shareholder returns. Together, these margins describe a portfolio where business quality varies — and where macro or sector headwinds could disproportionately impact the weaker-margin holdings.

Growth & Forward Outlook

Projected 12-month EPS growth of 10.3% is a constructive signal — measured earnings expansion supports the forward valuation case without relying on aggressive extrapolation. Zooming out from the valuation discussion, TTM revenue growth of 14.37% pointing to stable operational progress without outsized acceleration, while the estimated 12-month price change of 11.45%, where target prices point to mid-range appreciation potential from current levels. Anchoring to reported revenues provides discipline; analyst price targets add context about how the market currently values that operating reality. The path to realizing analyst-implied returns runs through revenue execution, margin stability, and a macro environment that doesn't undermine either. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Buy

Taken together, the metrics present a favorable setup — not without risk, but with enough quality and momentum to support a positive view.

The views expressed above are derived from quantitative data only and should not be relied upon as financial advice. Investment decisions should be based on your own research and risk tolerance.